Pachydermoperiostosis (PDP), also called primary hypertrophic osteoarthropathy (HOA), is a rare genetic disease with typical thickening of the skin (pachydermia) and rheumatic manifestations, with clubbing of the fingers and toes and periostosis of the long bones visible on X-rays, as well as arthritis in large joints sometimes. Case: We describe a 23-year-old man with a complete form of PDP who presented with polyarthritis of the ankles and knees, with clubbing of the fingers and toes. He was treated with a non-steroidal anti-inflammatory drug (NSAID), etoricoxib, and with bisphosphonates (initially pamidronic acid i.v. and later oral risedronate 35 mg weekly). His joint pains and swelling disappeared, so that he could resume his daily activities. After eight years, the periostosis on the X-rays had disappeared. Discussion: The case is discussed, the literature regarding PDP is summarized and the differential diagnosis and treatment options are reviewed. Conclusions: PDP may present as polyarthritis. Clinicians should be aware of this diagnosis, as treatment is available and may improve the outcome of the patient. It is important to rule out secondary HOA due to pulmonary or cardiac disease, gastrointestinal malignancies and liver cirrhosis, especially when the dermatological findings are not typical. Further, acromegaly, thyroid acropachy and rheumatologic diseases should be excluded.
1 January 2026 in Case Reports in Neurological Medicine
Cerebral venous sinus thrombosis (CVST) is an uncommon but potentially life‐threatening neurological complication of systemic lupus erythematosus (SLE) that requires prompt recognition and treatment. We report the case of an 18‐year‐old Bangladeshi woman with established SLE who presented with a 10‐day history of severe headache followed by rapidly progressive bilateral proptosis and sudden, painless bilateral visual loss. Neurological examination revealed complete bilateral visual loss, bilateral ptosis, restricted extraocular movements and multiple cranial nerve deficits. She had active SLE with severe thrombocytopaenia and haematological involvement. Brain magnetic resonance imaging and magnetic resonance venography demonstrated extensive thrombosis involving the superior sagittal, bilateral transverse and sigmoid and cavernous sinuses. Antiphospholipid antibody testing, including lupus anticoagulant, anticardiolipin antibodies and Anti‐β2‐glycoprotein I antibodies, was negative. The patient received therapeutic anticoagulation, high‐dose corticosteroids and immunosuppressive therapy with rituximab, followed by haematological and neurological improvement and subsequent recanalisation of the thrombosed dural venous sinuses. However, bilateral visual loss persisted, with optic disc pallor and optic atrophy. Optical coherence tomography, visual evoked potential testing, dedicated orbital imaging and formal neuro‐ophthalmological assessment were not performed; therefore, the precise mechanism of visual loss could not be definitively established. Nevertheless, ischaemic optic neuropathy was considered the most likely mechanism given the clinical presentation and extensive CVST. This case highlights that extensive CVST may occur in active SLE despite negative antiphospholipid antibody testing. It underscores the importance of early neuroimaging, timely anticoagulation and appropriate immunosuppressive therapy to minimise the risk of persistent neurological and visual sequelae.
1 October 2025 in International Journal of Case Reports and Images
Introduction: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired autoimmune disorder of the peripheral nervous system, while membranous nephropathy (MN) is a glomerular disease that may develop from exogenous risks or autoimmune conditions. Their coexistence is extremely rare and poorly understood. Case Report: We report a 55-year-old male from Bangladesh presenting with progressive symmetrical muscle weakness and both motor and sensory impairment in all four limbs. Nerve conduction studies demonstrated features consistent with inflammatory demyelinating polyneuropathy, and cerebrospinal fluid analysis revealed albuminocytological dissociation. The patient also developed nephrotic-range proteinuria; renal biopsy confirmed the diagnosis of membranous nephropathy. He was treated with pulse methylprednisolone and intravenous cyclophosphamide, resulting in improvement in both muscle strength and proteinuria, though sensory deficits persisted. Conclusion: This rare case of concurrent CIDP and MN suggests a shared autoimmune mechanism involving nerves and kidneys. Early recognition and treatment are essential to prevent irreversible neurological and renal damage, especially in resource-limited settings.